Alto Neuroscience, Inc. (ANRO)
24.91
-0.75
(-2.92%)
USD |
NYSE |
May 01, 16:00
24.91
0.00 (0.00%)
After-Hours: 17:41
Alto Neuroscience EPS Diluted (Quarterly) : -0.5069 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Eli Lilly & Co. | 8.255 |
| Immunovant, Inc. | -0.6095 |
| Halozyme Therapeutics, Inc. | -1.203 |
| Vertex Pharmaceuticals, Inc. | 4.651 |
| Fortress Biotech, Inc. | -0.1976 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -16.18M |
| Total Expenses (Quarterly) | 16.18M |
| Enterprise Value | 667.20M |
| Earnings Yield | -9.01% |
| Normalized Earnings Yield | -8.909 |